Netherlands · 
Who invested in Mimetas?
Mimetas's investors include InnovationQuarter, OostNL, EISMEA, PMV and Cathay Capital, and 5 more on record.
20152016201720182019
$1.6MSeed$5.2MSeries A$20MSeries B$3.5MGrant
Netherlands · Funded startup
Who invested in Mimetas
Funding summaryUpdated 26 Oct 2026
$30Mraised across 4 rounds since 2014, from 4 sources
$1.6MSeed$5.2MSeries A$20MSeries B$3.5MGrant
- Latest round
- Grant, $3.5MJan 2019
- Biggest round
- $20MSeries B · Apr 2018
- Investors
- 10
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $1.6M Sept 2014
- Biggest round
- $20M Series B · Apr 2018
- Usual gap between rounds
- 3.5 years the median of 2
The rounds
- Jan 2019
- Apr 2018Series B$20M6 new
Cathay Capital
InnovationQuarter
OostNL
Korys
Aglaia Oncology Fund- European Life Sciences
Reported by FinSMEs
- Oct 2014Series A$5.2M2 new
- Participatiemaatschappij Vlaanderen
- Zeeuws Investerings Fonds
From a historical funding record
- Sept 2014Seed$1.6M
No investor was named in the report.
From a historical funding record
Founders and team
From Mimetas's own website: 12 on the team.
- Jos JooreCo-Chief Executive Officer
- Paul VultoCo-Chief Executive Officer
- Mieke DoornbosVice President Marketing & Sales
- Remko van VughtVice President Business Development
- Bas TrietschChief Technology Officer
- Chiwan ChiangMarketing Specialist
- Frederik SchavemakerProduct Design Engineer
- Henriëtte LanzDirector of Model Development
- Lenie van den BroekDirector Biology Discovery
- Nienke WeversSenior Scientist
- Stefan KramerChair of the Board
- Tina ThakkarAssociate Director Sales
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Seed2014Series A2014Series B2018Grant2019InnovationQuarterOostNLEISMEA
PMVCathay CapitalKorysAglaia Oncology FundParticipatiemaatschappij VlaanderenEuropean Life SciencesZeeuws Investerings Fonds
InnovationQuarterOostNLEISMEAPMVCathay CapitalKorysAglaia Oncology FundParticipatiemaatschappij VlaanderenEuropean Life SciencesZeeuws Investerings FondsEveryone who backed them
EISMEAInvestment firm1round
Participatiemaatschappij VlaanderenInvestment firm1round
European Life Sciencesno record of our own yet1round
Zeeuws Investerings Fondsno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Mimetas as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Mimetas
How much has Mimetas raised?
Mimetas has raised $30M across 4 rounds since 2014.
When did Mimetas last raise?
Mimetas's most recent round was a Grant of $3.5M in Jan 2019.
What was Mimetas's biggest round?
Mimetas's largest round on record is $20M (Series B), in Apr 2018.
Who backed Mimetas first?
Mimetas's first round on record, in Oct 2014, was backed by Participatiemaatschappij Vlaanderen and Zeeuws Investerings Fonds.
What stage is Mimetas at?
Mimetas's latest named round is a Grant, in Jan 2019.
Where is Mimetas based?
Mimetas is based in the Netherlands.
Companies like Mimetas
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.